Publications by authors named "Steven F Francom"

Claim this Profile
C
Cerebrovascular accidents in patients treated for choroidal neovascularization with ranibizumab in randomized controlled trials.
Neil M Bressler, David S Boyer, David F Williams, Steven Butler, Steven F Francom

Retina· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of QTinno, a fully automated electrocardiographic analysis program, to semiautomated electrocardiographic analysis methods in a drug safety study in healthy subjects.
Nenad Sarapa, Ihor Gussak, Branislav Vajdic, Samuel George, Ljupco Hadzievski, Steven F Francom

J Electrocardiol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration.
David S Boyer, Jeffrey S Heier, David M Brown, Steven F Francom, Tsontcho Ianchulev

Ophthalmology· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of clinically significant QTc prolongation in phase I studies in healthy participants: comparison of 2 semiautomated QT measurement methods.
Nenad Sarapa, Steven F Francom, Sara M Azzam, Prachi K Wickremasingha, Benoit Tyl

J Clin Pharmacol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing methods of measurement for detecting drug-induced changes in the QT interval: implications for thoroughly conducted ECG studies.
Nkechi E Azie, Gregory Adams, Borje Darpo, Steven F Francom, Emery C Polasek

Ann Noninvasive Electrocardiol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single oral dose safety, tolerability, and pharmacokinetics of PNU-96391 in healthy volunteers.
Carlos A Rodríguez, Nkechi E Azie, Gregory Adams, Kirsteen Donaldson, Steven F Francom

J Clin Pharmacol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrocardiographic identification of drug-induced QT prolongation: assessment by different recording and measurement methods.
Nenad Sarapa, Joel Morganroth, Jean-Philippe Couderc, Steven F Francom, Borje Darpo

Ann Noninvasive Electrocardiol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacokinetics of linezolid are not affected by concomitant intake of the antioxidant vitamins C and E.
Toufigh Gordi, Lai Hock Tan, Catherine Hong, Nancy J Hopkins, Steven F Francom

J Clin Pharmacol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valdecoxib, a COX-2-specific inhibitor, does not affect cardiac repolarization.
Nenad Sarapa, Margaret R Britto, Barbara Cotton, Steven R Cox, Steven F Francom

J Clin Pharmacol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular effect of almotriptan in treated hypertensive patients.
Joseph C Fleishaker, Janet D McEnroe, Nkechi E Azie, Steven F Francom, Barbara J Carel

Clin Pharmacol Ther· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis